Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",41865,234,1.09 [0.94-1.27],0.2521727333648681
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43307,325,1.03 [0.90-1.18],0.6452251823556312
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",42875,2274,1.02 [0.97-1.08],0.3541830079486125
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,43348,710,1.11 [1.03-1.21],0.0103790524323293
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,42021,5805,1.02 [0.99-1.05],0.2785524827308846
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),42221,5257,1.01 [0.98-1.05],0.4747468884955761
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,42927,1992,1.00 [0.94-1.06],0.9496473896051836
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,43190,144,1.02 [0.83-1.26],0.8251274409810603
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,39964,1568,1.04 [0.98-1.10],0.2275544767971575
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38560,1755,1.04 [0.98-1.10],0.219797435115486
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,38448,417,1.10 [0.99-1.23],0.0881211832166151
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,30438,3240,1.02 [0.97-1.06],0.5030588275164827
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38199,638,1.01 [0.92-1.12],0.8230370720266955
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,43277,2342,1.01 [0.96-1.06],0.7628082543929572
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Mycoses,43475,837,1.11 [1.03-1.20],0.0092360961264481
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,42120,1519,1.02 [0.95-1.08],0.5934535807428662
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43363,1732,1.03 [0.97-1.09],0.298995175611132
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41262,327,1.03 [0.90-1.18],0.649438707151778
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,43563,75,1.03 [0.77-1.37],0.8497678089444488
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,43144,1513,1.04 [0.98-1.11],0.1916744470829863
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,43172,126,0.90 [0.70-1.16],0.4058549196918033
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43417,261,1.01 [0.87-1.18],0.882597010958588
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43389,233,0.99 [0.84-1.17],0.8832748063685552
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41277,676,1.00 [0.90-1.10],0.9416465021415716
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,41053,452,1.06 [0.94-1.18],0.3418912475448465
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,41098,163,1.04 [0.86-1.26],0.673337845764789
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,43522,90,0.90 [0.66-1.22],0.4974001134703757
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43449,264,0.89 [0.75-1.06],0.1960092754937951
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral warts,43273,88,0.81 [0.58-1.13],0.2087448494236932
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],43299,114,0.89 [0.68-1.16],0.3893217484009754
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm,43070,493,0.90 [0.79-1.02],0.0959109384652503
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43415,99,1.03 [0.81-1.32],0.794025585950897
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43377,108,1.07 [0.86-1.34],0.5538618120771628
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,19977,106,0.80 [0.59-1.10],0.1702940864074738
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",43002,2407,1.05 [1.00-1.10],0.0454122248081807
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of meninges,43538,96,0.79 [0.57-1.09],0.152581864498196
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43450,113,0.93 [0.72-1.21],0.6074598691994013
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,43521,170,1.07 [0.89-1.28],0.4654435052289474
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of ovary,23480,148,1.08 [0.89-1.30],0.4335809939368983
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,43519,615,1.06 [0.96-1.16],0.244264892286289
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Caecum,43531,500,0.97 [0.86-1.09],0.596488693737192
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43372,118,0.89 [0.68-1.16],0.3865143129228681
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,43521,370,1.06 [0.94-1.20],0.337754969847708
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Rectum,43447,590,1.08 [0.99-1.19],0.0897958118423082
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43364,1053,1.11 [1.03-1.19],0.0040245482477973
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,43514,714,1.07 [0.98-1.16],0.1611918501558233
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Carcinoma in situ of breast,19054,119,0.93 [0.73-1.19],0.5517369283166704
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19126,138,0.96 [0.77-1.19],0.6951623675033523
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",34720,90,0.59 [0.39-0.90],0.0151278022701078
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",34745,115,1.02 [0.81-1.28],0.8484515508981747
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43470,204,1.13 [0.97-1.31],0.1113408257526948
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Haemangioma, any site",43471,199,1.12 [0.96-1.30],0.1626266437418664
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Leiomyoma of uterus,22685,498,1.08 [0.98-1.19],0.134391262862462
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Lung cancer and mesothelioma,30266,581,1.07 [0.96-1.19],0.2007350606415788
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Lymphoid leukaemia,34720,90,0.70 [0.48-1.02],0.0654737258840928
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34944,314,1.05 [0.92-1.20],0.4379091615501629
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",34963,333,0.99 [0.86-1.13],0.8460254124878336
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19251,160,0.97 [0.79-1.19],0.7560178117642595
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",34769,139,1.19 [1.00-1.42],0.0483731578126852
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",34799,169,0.86 [0.69-1.08],0.2002629189147227
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",34801,171,1.02 [0.84-1.23],0.8348156090872161
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19220,129,0.86 [0.67-1.12],0.2613275651044657
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",34785,155,0.94 [0.75-1.16],0.5470816013962476
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16684,1145,0.92 [0.85-1.00],0.0527018064912671
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",34823,193,0.97 [0.81-1.17],0.7758395506910685
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",34754,124,1.04 [0.83-1.29],0.7533565362129058
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,34803,173,0.97 [0.79-1.18],0.7364394565445871
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Melanocytic naevi,43233,342,1.04 [0.91-1.18],0.5804664629095839
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Melanocytic naevi of trunk,43497,151,1.02 [0.83-1.24],0.8832450705076726
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Melanoma in situ,34686,135,1.05 [0.85-1.28],0.6596692451906876
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",34784,154,1.02 [0.84-1.25],0.826904811480671
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34892,262,1.06 [0.91-1.22],0.4481916340461918
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",35030,400,1.00 [0.88-1.14],0.9761352008929588
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",34791,161,1.05 [0.87-1.26],0.6234083229203056
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Other benign neoplasms of skin,43256,274,0.89 [0.75-1.06],0.1778950312339598
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",36428,1798,1.04 [0.98-1.10],0.1948948182428108
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",36523,1893,1.04 [0.98-1.10],0.2011288678397996
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,43065,582,1.02 [0.92-1.12],0.7737214729940366
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,40433,148,1.05 [0.87-1.28],0.6055704124035701
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,42609,126,1.12 [0.93-1.37],0.2382729253814844
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,42266,4796,1.01 [0.98-1.05],0.4739678379569417
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,41169,77,1.06 [0.81-1.39],0.652298383848427
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,42874,85,0.88 [0.64-1.20],0.40896091008565
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,42777,2492,1.01 [0.96-1.06],0.683449137376272
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,42775,2490,1.01 [0.96-1.06],0.672899694664756
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,40427,142,1.19 [1.00-1.41],0.047390776855019
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,43028,1936,1.03 [0.97-1.09],0.3384553221318289
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,42981,192,1.05 [0.88-1.24],0.5999757287133972
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,42586,103,1.16 [0.94-1.43],0.1738408286921131
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,42589,106,1.14 [0.93-1.41],0.2081127042230637
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,43241,452,0.92 [0.81-1.05],0.2337707197787914
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,43390,91,1.22 [0.99-1.50],0.0574929062453611
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",43167,378,0.92 [0.80-1.06],0.2380554726865327
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,41266,174,0.87 [0.69-1.08],0.2065085333648671
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,33810,502,0.95 [0.84-1.08],0.4546649828787841
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,40606,190,1.02 [0.84-1.23],0.8458715201569792
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,40631,215,1.13 [0.97-1.32],0.1134780004198958
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,33400,92,1.10 [0.87-1.40],0.4169031399011856
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,40480,107,1.14 [0.92-1.40],0.2362941530704987
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,39549,383,1.06 [0.94-1.20],0.3256402779686063
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",42800,883,1.00 [0.92-1.09],0.942776155873671
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,42365,448,1.01 [0.90-1.14],0.8250465960645383
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,42097,180,0.87 [0.70-1.08],0.2033414162147233
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,42986,2613,0.99 [0.94-1.04],0.567375486318348
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,38048,2542,0.99 [0.94-1.04],0.6680848526264443
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",33410,102,0.75 [0.53-1.05],0.0912802566524697
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",40251,135,0.99 [0.79-1.23],0.8977672851548701
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,33759,451,1.06 [0.95-1.19],0.2766872639329116
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,33409,101,0.95 [0.72-1.25],0.7131371474544108
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,39220,5912,1.02 [0.99-1.05],0.209777040550766
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,33646,338,1.14 [1.01-1.28],0.036999120322363
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,34229,921,1.06 [0.98-1.15],0.1590745346070245
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43432,525,0.98 [0.88-1.10],0.7364452244936064
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,43117,210,1.09 [0.93-1.28],0.2744364740645159
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,33526,218,0.90 [0.74-1.10],0.303509653111005
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",33411,103,0.98 [0.76-1.27],0.901983014068814
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,42659,2543,1.05 [1.00-1.10],0.0368460940925904
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,33723,415,0.93 [0.81-1.07],0.307419680962899
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,33761,453,1.05 [0.94-1.18],0.3878367460717716
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34366,1058,1.01 [0.94-1.10],0.716198020313168
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,33487,179,0.98 [0.80-1.19],0.8362919450914403
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,43106,199,1.09 [0.92-1.28],0.3153723153610491
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,34316,1008,0.98 [0.90-1.06],0.6171081241944967
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,34119,811,1.05 [0.96-1.14],0.2807548488426766
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,39276,110,0.91 [0.70-1.19],0.4880371255809922
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41650,8342,1.02 [0.99-1.05],0.116110074041629
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,40191,75,1.02 [0.77-1.36],0.8853880166989274
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,40211,95,1.07 [0.84-1.36],0.5756442032690032
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,43256,3246,1.02 [0.97-1.06],0.4457039383825726
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",43257,3241,1.02 [0.97-1.06],0.4172426608873828
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,40202,86,0.62 [0.41-0.94],0.0253822072345608
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,42990,2027,1.05 [0.99-1.11],0.081081388454602
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",35909,2601,1.01 [0.96-1.06],0.6507858939416472
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,43545,348,0.97 [0.84-1.11],0.6312206450886015
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,42038,121,0.92 [0.71-1.18],0.5086154802791389
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,41140,177,0.89 [0.72-1.11],0.2958833979728114
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,41203,240,1.03 [0.88-1.21],0.6801500696328976
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",33578,270,1.05 [0.90-1.21],0.5443212674396576
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39651,263,1.01 [0.87-1.19],0.8721057325979105
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3584,138,0.83 [0.64-1.08],0.16229145992765
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3819,418,1.02 [0.91-1.15],0.7119390066149455
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,39492,104,1.16 [0.94-1.45],0.1721941290046289
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3526,81,0.86 [0.61-1.19],0.3592469755759079
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,42513,3125,0.99 [0.94-1.03],0.603435538905549
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,42472,555,0.97 [0.87-1.08],0.5710632901994448
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,39771,605,1.04 [0.94-1.15],0.405864998717758
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34546,1238,1.04 [0.97-1.12],0.2493013833160002
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43370,410,1.16 [1.04-1.29],0.0059081085925711
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),41687,271,0.96 [0.82-1.13],0.6570131585216452
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Angina pectoris,39843,1986,0.96 [0.91-1.02],0.2345193303952245
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,41817,401,1.01 [0.89-1.14],0.8944023449642108
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,41514,98,1.14 [0.91-1.43],0.2389143088105569
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",41746,330,1.14 [1.02-1.29],0.0267933335533152
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,26981,3107,1.02 [0.97-1.06],0.4658620809804589
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,AV-block,36831,705,1.02 [0.92-1.12],0.7553512591577511
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43461,690,1.01 [0.92-1.11],0.7732666535977436
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,24184,310,0.95 [0.82-1.11],0.5383445059824519
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36410,284,0.99 [0.85-1.16],0.9113422569303684
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",36284,158,1.04 [0.86-1.26],0.6829519148486555
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,43559,74,0.99 [0.73-1.32],0.9214680093610872
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Conduction disorders,37860,1734,1.02 [0.96-1.09],0.4463458948819921
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,41296,3471,0.96 [0.92-1.00],0.0798091593340179
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,38117,12789,1.00 [0.98-1.02],0.8892559864982373
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,41260,444,1.17 [1.06-1.29],0.0016941450684204
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Endocarditis,36244,118,1.00 [0.79-1.26],0.9684553088875671
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",43213,1817,0.99 [0.94-1.05],0.8393118164140474
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Hypertension,39659,10949,1.00 [0.97-1.02],0.6982566070025911
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",39672,10962,0.99 [0.97-1.02],0.6734745526285499
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",43264,133,1.25 [1.05-1.47],0.0100878391455599
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29025,315,0.97 [0.83-1.12],0.6530091568643466
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28876,166,1.02 [0.84-1.24],0.8187905350986135
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Hypotension,43322,1899,0.97 [0.91-1.03],0.3038257501868599
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,42044,172,1.08 [0.91-1.29],0.3867138074105735
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",41603,3746,0.97 [0.93-1.02],0.2073180211751272
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",42952,929,1.08 [1.00-1.16],0.0498301872648425
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,36731,605,1.06 [0.96-1.17],0.2324562137021968
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,42787,1404,0.93 [0.86-1.00],0.0424138964911404
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",39042,1185,0.91 [0.83-0.98],0.0183793384751699
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43403,268,0.79 [0.65-0.96],0.018605041017431
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",43512,523,0.96 [0.86-1.08],0.4991935664134467
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,40903,87,0.89 [0.66-1.21],0.4728396261790715
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other aneurysm,41543,127,1.01 [0.80-1.26],0.9551611589141727
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,36836,710,0.97 [0.88-1.07],0.5801319104228979
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,41585,169,1.02 [0.84-1.24],0.8657501307246673
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41810,394,1.07 [0.95-1.20],0.2722734822507827
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,36426,300,0.97 [0.84-1.13],0.7372626432191443
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,40965,149,1.07 [0.88-1.30],0.522048893340511
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,40899,83,1.25 [1.01-1.55],0.0370640218081624
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,41214,104,1.15 [0.93-1.42],0.2065667241917962
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,41035,219,1.14 [0.99-1.32],0.0775930214719068
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37811,1685,1.00 [0.94-1.06],0.8959300187012599
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,41513,90,0.76 [0.54-1.08],0.1286277717211028
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42314,898,1.07 [0.98-1.15],0.1143809459328104
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42529,587,1.02 [0.92-1.13],0.7674730254732112
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",42106,996,1.01 [0.93-1.09],0.8207513192550306
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24425,551,0.97 [0.87-1.09],0.6237234225386501
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,42031,666,1.06 [0.96-1.16],0.2514661488648614
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41391,575,1.12 [1.03-1.23],0.0122959549891332
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,42726,784,1.00 [0.91-1.09],0.9569795224976836
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43437,1074,0.97 [0.89-1.05],0.3882683608735641
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,36699,573,1.00 [0.90-1.12],0.950453941267395
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,42521,579,1.01 [0.91-1.12],0.8466597293592792
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,41420,310,0.94 [0.80-1.09],0.4000733430490262
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",42929,1057,1.07 [1.00-1.15],0.0540097827389747
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",42893,1121,1.07 [1.00-1.15],0.0531874231035572
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,41995,95,0.99 [0.76-1.29],0.9558537760510132
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,41547,132,1.02 [0.82-1.26],0.8835171612622458
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,42394,371,1.08 [0.96-1.22],0.1828671169081465
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41809,426,0.92 [0.80-1.05],0.2186612894750981
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Varicose veins,41512,696,1.08 [0.99-1.18],0.0757423131088899
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,41440,141,1.04 [0.85-1.28],0.7082075623097526
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,43175,1236,1.05 [0.98-1.13],0.1397676619646848
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43353,601,1.05 [0.95-1.16],0.3531329461658039
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",38164,2385,1.04 [0.99-1.09],0.1632281832728264
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,Any mental disorder,42472,6693,1.01 [0.98-1.04],0.4023066993041857
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43276,704,1.08 [0.99-1.18],0.1032113841367431
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",38440,2661,0.99 [0.94-1.04],0.7357875461208001
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",35919,140,0.85 [0.65-1.10],0.2065873587268303
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,Smoking dependency,42655,2319,1.01 [0.96-1.06],0.7449754291319612
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",38532,2753,1.01 [0.96-1.06],0.6847107629430067
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,Vascular dementia,42764,210,0.97 [0.81-1.16],0.752200757206301
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Alzheimer disease,43561,559,1.04 [0.94-1.15],0.4517901110277278
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",29532,94,1.06 [0.84-1.35],0.619633569984711
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Bell's palsy,40577,135,1.14 [0.95-1.38],0.1562655547765981
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41282,840,0.97 [0.88-1.06],0.4455466857017293
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Cerebral cysts,42883,369,1.12 [1.00-1.25],0.0604929482986374
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43422,516,0.95 [0.85-1.07],0.430810265002252
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,42744,94,0.87 [0.64-1.17],0.3539105148971976
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,43534,109,1.05 [0.83-1.32],0.7005169965130799
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",42629,115,1.09 [0.88-1.35],0.4540628737542446
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Epilepsy,40974,474,0.97 [0.86-1.09],0.5744194797891917
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,42753,2253,0.96 [0.91-1.01],0.1493037654610753
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,43486,703,1.04 [0.95-1.13],0.4465856929739243
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,42573,4253,1.01 [0.97-1.05],0.6818445953395417
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,42935,93,1.10 [0.87-1.39],0.4424675305056845
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Hemiplegia,43314,408,0.96 [0.84-1.09],0.5345731621526961
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Hydrocephalus,42616,102,0.87 [0.65-1.16],0.347950083332475
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,43529,118,0.83 [0.62-1.10],0.1885259935778434
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,40571,129,1.00 [0.80-1.24],0.9869325769446144
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,40572,130,0.98 [0.78-1.23],0.8737763962593272
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Memory loss,42521,194,0.92 [0.75-1.12],0.4136218391834271
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Migraine,41097,597,0.93 [0.83-1.04],0.1769836155591739
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43442,542,0.96 [0.86-1.07],0.4863160460631393
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Motor neuron disease,29731,256,0.85 [0.70-1.03],0.0938692581549884
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43265,183,0.81 [0.64-1.02],0.0690314406832649
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42443,2001,1.00 [0.94-1.06],0.9588343160264045
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Neurological diseases,41051,6108,1.01 [0.98-1.04],0.6308126624920029
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,42960,310,1.03 [0.90-1.19],0.6335957414242029
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",41113,671,1.04 [0.94-1.14],0.4521613365578478
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",43431,485,1.04 [0.93-1.16],0.5427156031944063
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,34864,1077,1.00 [0.93-1.08],0.9278555186275383
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,42633,119,0.99 [0.79-1.26],0.9553827816781872
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,42749,235,0.93 [0.77-1.11],0.4064572532240084
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,43031,248,1.02 [0.87-1.19],0.7955328912384916
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,40602,160,1.09 [0.91-1.31],0.3389327348973944
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other headache syndromes,40597,97,0.72 [0.51-1.03],0.0706837620846796
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other neurological diseases,43364,850,1.04 [0.95-1.13],0.4166406905420595
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other sleep disorders,41427,927,0.92 [0.84-1.01],0.0872992651301694
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Parkinson's disease,43517,414,1.05 [0.93-1.18],0.4212769248720101
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,42605,91,1.15 [0.92-1.43],0.2137446765574257
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,43559,111,1.03 [0.82-1.30],0.7685831041379324
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Sleep apnoea,43160,803,0.93 [0.85-1.03],0.177113011674294
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,43028,82,1.12 [0.88-1.43],0.3661043648706571
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,43533,300,0.86 [0.72-1.02],0.0829179380243668
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,40527,85,0.65 [0.44-0.98],0.0391356049292123
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,43561,565,1.03 [0.93-1.14],0.5202314025049832
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),42697,203,0.94 [0.78-1.13],0.4986776852437355
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,42611,159,0.74 [0.56-0.96],0.0260132857944373
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,42883,655,1.00 [0.90-1.10],0.9423039413167454
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43286,391,1.07 [0.95-1.21],0.2767128865564554
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,41856,91,1.09 [0.86-1.38],0.4751023232511353
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,41867,102,1.13 [0.91-1.40],0.2520861191611536
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",43377,86,1.16 [0.92-1.46],0.2040177310743843
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,43128,244,1.07 [0.92-1.24],0.4103005796255931
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3532,86,0.85 [0.61-1.18],0.3271628235820409
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4276,160,0.84 [0.66-1.06],0.1446781604671635
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,42616,164,1.01 [0.83-1.23],0.893509182113879
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,43221,1738,0.99 [0.93-1.06],0.8105993582526567
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42934,1169,1.04 [0.97-1.12],0.2424790221890076
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,42143,378,1.03 [0.91-1.17],0.6045256413619955
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43424,1196,0.99 [0.92-1.07],0.8463481271647881
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,43548,117,1.21 [1.01-1.46],0.0437962700349205
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,43305,1077,1.00 [0.93-1.08],0.9865952438276524
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",43492,608,1.01 [0.91-1.11],0.904508377050525
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,43402,305,0.95 [0.82-1.11],0.5430054308484279
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,41867,102,0.98 [0.76-1.26],0.8552295382797488
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,41878,113,0.76 [0.55-1.03],0.0807049153642635
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,41862,97,0.95 [0.73-1.25],0.7328356464586556
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43402,1183,1.06 [0.99-1.14],0.0763698917797415
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,42530,311,0.92 [0.79-1.08],0.3227683159830501
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,42307,79,0.83 [0.59-1.17],0.2807475374699448
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,43052,168,0.93 [0.75-1.15],0.4913606794808763
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,43339,455,1.06 [0.95-1.18],0.3197548731420963
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,42553,325,1.02 [0.89-1.17],0.8017091306576882
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,43280,183,1.03 [0.86-1.23],0.7487035438284205
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42991,772,1.09 [1.00-1.18],0.0535797791989741
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,42682,230,0.87 [0.72-1.06],0.156697530403842
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,40886,3677,1.02 [0.98-1.06],0.3452713462799318
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,43280,396,1.08 [0.97-1.22],0.1723320620412078
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,43526,255,0.90 [0.76-1.08],0.2616479640358646
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42458,693,1.03 [0.94-1.13],0.4875946862732251
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,43001,117,0.89 [0.68-1.16],0.3973256943365663
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,43524,93,1.13 [0.90-1.42],0.2988737466307208
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,41906,141,1.11 [0.92-1.34],0.2773725768179238
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,42020,255,1.03 [0.89-1.20],0.6753438394585198
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,41674,191,0.91 [0.74-1.11],0.3388838949606917
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,42323,95,0.86 [0.64-1.17],0.3431490081233248
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",41593,110,0.99 [0.78-1.26],0.942318562884088
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,42362,143,1.12 [0.93-1.35],0.2201960503330381
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",42542,323,1.04 [0.91-1.19],0.53248944387005
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,41970,205,1.15 [0.99-1.34],0.0617103087596991
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,41667,184,1.17 [1.01-1.36],0.0400162589759559
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,41616,133,1.03 [0.83-1.27],0.818844505395721
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,40201,2992,0.98 [0.93-1.02],0.3332584342372645
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,41887,122,0.98 [0.78-1.24],0.883926895556637
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,43135,683,0.91 [0.81-1.01],0.0782978776820472
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,42549,97,1.01 [0.78-1.31],0.9395435331181802
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),42721,269,1.04 [0.89-1.20],0.6337342776357154
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,43188,149,0.87 [0.69-1.11],0.2649432781563853
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,43485,200,1.01 [0.84-1.20],0.951325001692272
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,43342,217,0.78 [0.62-0.97],0.0254029136713119
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,43145,106,1.11 [0.89-1.37],0.3626804133384516
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,43152,113,1.07 [0.86-1.33],0.5515848324106325
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,43386,1472,0.95 [0.89-1.02],0.1534482043710081
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,42961,1047,0.95 [0.87-1.03],0.1907511795675888
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,42125,211,1.08 [0.92-1.27],0.3367491549784366
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,42055,141,1.01 [0.82-1.24],0.9445988304023756
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,43131,117,1.01 [0.80-1.27],0.9240471825919716
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43380,366,1.09 [0.97-1.23],0.1619062421981709
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,43125,111,1.09 [0.88-1.36],0.4387200624404629
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,All influenza,40243,193,1.03 [0.86-1.23],0.7657973360562843
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),40239,189,1.02 [0.85-1.22],0.8085041409661918
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),29887,202,1.20 [1.04-1.38],0.0147283526141973
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,43353,476,0.99 [0.88-1.12],0.901506226500797
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32251,3017,1.03 [0.98-1.08],0.2213934669758125
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",32654,2969,1.02 [0.98-1.07],0.3732677536136867
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),42876,234,1.13 [0.98-1.30],0.1050905018491686
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",40184,134,1.20 [1.00-1.43],0.047966835331477
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Bronchiectasis,37708,585,0.84 [0.74-0.95],0.0072297188803151
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",37219,96,0.98 [0.75-1.28],0.8986839099594452
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,41845,4722,1.01 [0.97-1.05],0.6204460781635415
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",41226,124,1.02 [0.81-1.27],0.8773063233470882
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,41356,254,1.01 [0.86-1.18],0.901822814180494
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",43226,1982,1.00 [0.95-1.06],0.9703937718619312
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,41291,189,0.93 [0.76-1.13],0.4533166060103952
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40055,8787,1.00 [0.97-1.03],0.9572598541991896
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41731,629,0.95 [0.85-1.05],0.3094803470611746
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Early onset COPD,41787,543,1.01 [0.91-1.12],0.8822449704040962
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Emphysema,37653,530,1.03 [0.92-1.15],0.6243540624966981
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41307,502,0.98 [0.88-1.10],0.7833799103307151
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,43175,3125,1.01 [0.96-1.05],0.8243128600644928
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,41364,559,0.98 [0.88-1.10],0.7655866448322304
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Later onset COPD,41844,1439,0.99 [0.93-1.06],0.8308259379622591
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,43538,509,0.94 [0.83-1.06],0.3207966981359253
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Nasal polyp,41289,187,0.90 [0.73-1.11],0.3106597537936095
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,43127,1601,1.01 [0.95-1.07],0.8238827196218594
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,43158,3316,1.02 [0.98-1.07],0.3259508751912705
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42527,1425,0.98 [0.92-1.05],0.6019426530192468
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other pleural conditions,39929,87,0.70 [0.48-1.03],0.0694411311811067
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43396,690,0.98 [0.88-1.08],0.6328195592670218
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,43373,2172,1.03 [0.98-1.09],0.2309577763957989
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pleural effusion,41468,1626,1.00 [0.94-1.06],0.9714648522644184
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pleural plaque,40111,269,1.05 [0.90-1.21],0.5305573617789816
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",42755,2705,0.99 [0.94-1.04],0.5868783248992853
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,43429,400,0.95 [0.83-1.09],0.4835720738667217
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pneumothorax,40046,204,1.02 [0.85-1.21],0.8675403756850227
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pollen allergy,43522,407,0.97 [0.85-1.10],0.6375240937059357
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,42815,109,0.96 [0.74-1.24],0.7598934444101298
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,29777,92,0.85 [0.62-1.16],0.3084793543978739
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,43091,1565,1.01 [0.94-1.07],0.8320545429670898
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,41579,477,0.99 [0.88-1.11],0.8854980043665102
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Viral pneumonia,40453,403,1.05 [0.93-1.18],0.442894431426896
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",42903,333,1.05 [0.92-1.20],0.4958715198335407
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20131,187,1.04 [0.87-1.25],0.6430895224308013
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30878,109,0.89 [0.67-1.17],0.4095648546697402
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute appendicitis,43282,239,1.04 [0.89-1.21],0.6521222040844585
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute gastritis,32840,145,1.12 [0.93-1.35],0.2500593912332252
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,40468,313,1.08 [0.95-1.23],0.2448135115468272
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute peritonitis,42771,149,1.09 [0.90-1.31],0.389879269397978
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,42069,125,1.26 [1.06-1.50],0.0096638691753777
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,33417,722,1.01 [0.92-1.11],0.801016981637934
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",40323,168,1.13 [0.95-1.34],0.1598597998273864
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",42870,168,1.12 [0.95-1.33],0.1773464629763574
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Cholecystitis,40487,332,1.15 [1.02-1.30],0.0177487309738947
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Cholelithiasis,41870,1715,1.06 [1.01-1.13],0.0306312679862755
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Chronic gastritis,33204,509,1.09 [0.99-1.21],0.0944095850414706
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,40237,82,1.05 [0.80-1.37],0.7346693619989747
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",43316,185,1.21 [1.04-1.40],0.0125144785051401
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Coeliac disease,40875,198,1.21 [1.05-1.39],0.0081296956384437
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Collagenous colitis,40733,131,1.04 [0.85-1.29],0.6796948662143802
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43296,322,1.04 [0.91-1.19],0.5857459905372004
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Constipation,43126,2741,0.96 [0.92-1.01],0.161261215158942
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Crohn disease,40744,142,0.95 [0.76-1.19],0.6321894576226723
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",42970,102,0.96 [0.73-1.24],0.7359264816073607
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40736,134,0.97 [0.78-1.22],0.8196150385894991
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Dental caries,42314,385,1.00 [0.87-1.13],0.9485566303553098
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,39106,3702,1.01 [0.97-1.05],0.7607964166180183
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of appendix,43345,302,1.02 [0.89-1.17],0.784539396789441
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of liver,43357,1413,1.03 [0.96-1.10],0.3781101873439094
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",39895,7200,1.02 [0.99-1.05],0.1200121717550838
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42853,924,1.08 [1.00-1.16],0.0603324544769159
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,43412,790,1.03 [0.95-1.13],0.4546446444548997
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,42114,185,1.01 [0.84-1.22],0.901540476973849
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,41876,102,1.00 [0.78-1.28],0.9973683635489352
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,43045,2368,1.03 [0.97-1.08],0.3377443719043355
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of tongue,41893,183,1.09 [0.92-1.29],0.3160896130385066
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42538,2383,1.05 [1.00-1.10],0.0451345762328396
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36076,5307,1.01 [0.97-1.04],0.6204751472977958
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,33025,330,1.00 [0.87-1.15],0.986674169016748
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43406,261,1.00 [0.86-1.17],0.97360973830718
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43418,89,1.01 [0.78-1.30],0.967754478199442
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,42164,220,1.16 [1.01-1.34],0.0407502428513048
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,31020,251,1.06 [0.92-1.23],0.4184837322237138
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,33615,920,1.03 [0.95-1.11],0.5173718140370575
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastric ulcer,33304,609,1.06 [0.96-1.17],0.2492177277457982
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,36876,4181,1.02 [0.98-1.06],0.392499004179629
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33604,909,1.04 [0.96-1.13],0.3796827818476527
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,33726,13886,1.03 [1.01-1.05],0.0146162674593703
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,GI-bleeding,42600,1923,1.02 [0.96-1.08],0.5073784702114892
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,42032,103,1.15 [0.94-1.42],0.1821469559635122
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,32402,2114,1.02 [0.97-1.08],0.485858021496634
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",42046,102,1.06 [0.83-1.34],0.6612084173920474
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Hernia,40802,5398,0.99 [0.96-1.03],0.7150580467469547
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Impacted teeth,43429,83,0.98 [0.74-1.30],0.8935138900893033
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Impaction of intestines,30866,97,0.94 [0.72-1.24],0.6712176026404675
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Inguinal hernia,36914,1510,1.01 [0.94-1.07],0.8448334573941494
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",35574,170,0.94 [0.77-1.16],0.5900702287110751
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,30924,155,1.12 [0.94-1.33],0.2166021517888717
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,40914,237,1.13 [0.99-1.30],0.0804163923559872
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31693,924,1.01 [0.93-1.09],0.8231770167956497
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,43516,610,0.94 [0.84-1.05],0.2842619406847582
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41861,1259,1.03 [0.96-1.10],0.4588153443470349
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42280,1678,1.01 [0.95-1.07],0.849342935943823
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,32998,303,1.00 [0.87-1.16],0.9744303692350595
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Oesophagitis,33702,1007,1.04 [0.96-1.12],0.3640611539500857
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43474,229,0.97 [0.82-1.15],0.715363420060764
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,35517,113,1.13 [0.92-1.38],0.2324782380728271
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,33055,2286,0.96 [0.91-1.01],0.1210101700992574
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40620,465,1.01 [0.90-1.14],0.8495132898614559
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,40418,263,1.15 [1.01-1.31],0.0391065947100467
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,33719,2950,1.00 [0.95-1.04],0.9117960676977231
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,40171,9402,0.99 [0.97-1.02],0.6273417196055509
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41865,347,1.05 [0.92-1.19],0.4930566611716722
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of liver,43096,1152,1.01 [0.94-1.09],0.7693192119257797
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,33800,1105,1.01 [0.94-1.09],0.7342072417641456
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,40398,243,0.97 [0.82-1.15],0.7399664153369453
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43303,681,1.07 [0.98-1.17],0.1541046563773781
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,34278,1583,1.01 [0.94-1.07],0.870357385610818
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,42624,1947,1.02 [0.96-1.07],0.59420840661934
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,42222,293,1.09 [0.95-1.25],0.2023246697737301
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,33590,2821,0.96 [0.91-1.01],0.1034176510522325
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),36057,3362,1.01 [0.96-1.05],0.7509799284685832
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,42112,168,1.13 [0.95-1.34],0.1657432103095488
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,42076,1474,1.01 [0.95-1.08],0.7304428700817178
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31345,576,1.02 [0.92-1.13],0.6827535977362493
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43399,105,0.96 [0.74-1.24],0.7474789811604812
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31589,820,1.02 [0.94-1.11],0.6422500034519092
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40938,261,0.95 [0.80-1.12],0.5466993370447499
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,43540,97,1.17 [0.95-1.44],0.1350851080814579
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,41932,196,1.21 [1.06-1.40],0.0063903278685829
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Toxic colitis,40697,95,0.97 [0.74-1.27],0.8120086749046005
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33159,464,0.99 [0.88-1.12],0.8611235753466637
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,40872,270,0.89 [0.74-1.06],0.1799708745887321
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40828,226,0.89 [0.74-1.08],0.2328125931786746
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Umbilical hernia,35854,450,0.89 [0.78-1.02],0.1002864349750744
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,31066,297,0.99 [0.85-1.14],0.8554543783264799
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Ventral hernia,35836,432,0.97 [0.85-1.10],0.6172691433881368
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Volvulus,30902,133,1.08 [0.88-1.32],0.4603552725047871
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,43431,488,1.07 [0.97-1.19],0.1780656822298313
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,43023,136,0.95 [0.75-1.19],0.6489993356273492
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,40175,275,0.93 [0.79-1.09],0.3818102260685284
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42478,1175,1.06 [0.99-1.14],0.0910562913606288
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41600,297,1.05 [0.92-1.21],0.4676155575528755
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,40542,642,0.99 [0.90-1.10],0.8693839580003438
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,43037,463,1.04 [0.93-1.16],0.5179447338545784
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43381,807,1.02 [0.94-1.12],0.5903149637055294
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,42656,82,1.07 [0.83-1.39],0.5847797008285519
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,40952,5376,1.00 [0.97-1.04],0.8537878360077229
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42801,741,0.96 [0.87-1.05],0.3633627481595444
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42574,514,0.95 [0.84-1.06],0.3577008634510549
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,42894,1591,1.06 [1.00-1.13],0.048047474841725
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",43533,91,0.89 [0.66-1.20],0.441957999871073
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,40011,111,0.98 [0.77-1.25],0.8805581906629794
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,42152,92,1.00 [0.76-1.30],0.9863160622469704
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,43019,445,1.03 [0.92-1.16],0.5922106839903345
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40666,766,1.06 [0.97-1.15],0.1719837596308192
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,40010,110,0.97 [0.76-1.24],0.8113474472016646
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,43415,136,0.93 [0.74-1.18],0.5680238999512615
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,41598,295,1.07 [0.93-1.22],0.354731464040153
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,43212,325,1.00 [0.86-1.15],0.9461747031903348
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,42674,100,0.91 [0.68-1.20],0.4875911392947237
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,40009,109,0.94 [0.72-1.21],0.6163293745622074
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,42602,2702,0.99 [0.94-1.04],0.7153590002631272
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40734,834,1.05 [0.97-1.14],0.2288293578142504
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,40017,117,0.94 [0.73-1.21],0.6237318935343735
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43414,527,0.95 [0.84-1.06],0.3454631562455997
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,42694,120,1.10 [0.89-1.35],0.384002356125238
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43320,433,0.97 [0.85-1.10],0.585100036838099
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,43474,531,1.05 [0.95-1.16],0.3461897433611405
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,40118,218,0.90 [0.74-1.09],0.2610100890811648
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40341,441,0.94 [0.83-1.07],0.371805635738743
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,43456,513,1.05 [0.95-1.17],0.3317934200672744
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",40279,379,1.08 [0.96-1.21],0.225330801269018
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,43506,227,0.96 [0.81-1.15],0.6716060011972884
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,37355,186,1.09 [0.92-1.29],0.3264074101699542
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39629,9457,1.01 [0.98-1.04],0.4803014543438735
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37276,7104,1.01 [0.98-1.04],0.6902339097800112
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,37298,129,1.10 [0.90-1.34],0.3699424014448134
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37806,255,1.01 [0.87-1.18],0.875618839460592
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37849,298,0.96 [0.82-1.12],0.6079647825536687
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,43140,156,0.80 [0.62-1.03],0.0823751098816106
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",37716,165,1.02 [0.84-1.24],0.8470996244475588
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,32083,1911,1.00 [0.95-1.06],0.9197451827632328
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43323,324,0.88 [0.75-1.03],0.1091470737587211
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38265,714,1.00 [0.91-1.10],0.9656197793883728
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36804,12198,1.01 [0.99-1.04],0.3089690159684743
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40234,207,0.81 [0.65-1.01],0.0582523494297307
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,37425,256,1.10 [0.96-1.27],0.184223171771764
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,38139,970,1.06 [0.98-1.14],0.1538556340078136
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,41983,4432,0.99 [0.96-1.03],0.689924989567548
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37634,465,0.93 [0.82-1.06],0.2586138715811589
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,37547,378,0.96 [0.84-1.10],0.5508274393923536
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37403,234,1.05 [0.90-1.23],0.5038594647868656
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,42432,121,0.76 [0.56-1.02],0.0693985329435953
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,33008,2836,1.00 [0.96-1.05],0.8963792728956006
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,31143,971,1.06 [0.98-1.14],0.1396290726143122
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43428,956,1.04 [0.97-1.13],0.2763791128073529
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30296,124,0.96 [0.76-1.22],0.75421659755485
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30735,563,1.12 [1.02-1.23],0.0162471444919973
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37677,508,1.09 [0.98-1.20],0.105418347660705
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31258,1086,0.97 [0.90-1.05],0.4900020832632098
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,37640,89,0.92 [0.69-1.24],0.5882982852522073
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38605,1054,0.95 [0.88-1.03],0.2454605988266425
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,38054,503,1.03 [0.93-1.15],0.5645691509329723
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31183,1011,0.97 [0.89-1.05],0.4408989208470558
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,37299,130,0.86 [0.66-1.12],0.2524466945257589
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",37269,100,1.01 [0.79-1.30],0.9439563490467076
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,40147,120,0.92 [0.71-1.19],0.5326127715781473
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,42910,2883,0.96 [0.91-1.01],0.1048905253571873
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,41915,1888,0.96 [0.90-1.02],0.1897076462616418
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43317,764,0.96 [0.88-1.06],0.4524612810483107
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,34374,4202,1.03 [0.99-1.07],0.1415863435906274
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30275,103,1.08 [0.87-1.36],0.4866613950830192
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,37322,153,1.00 [0.81-1.23],0.99080152588097
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30261,89,1.13 [0.90-1.42],0.3022970199089135
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30389,217,1.17 [1.01-1.35],0.0306043907759773
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40440,413,0.96 [0.85-1.10],0.5819445303362708
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,40648,621,0.97 [0.88-1.08],0.6217545846440777
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,43509,163,0.92 [0.74-1.14],0.4625286283551698
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",40569,3018,0.98 [0.94-1.03],0.4782561833462295
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37337,168,1.00 [0.82-1.21],0.9798808219514796
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30411,239,1.05 [0.90-1.22],0.5623833364842798
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38760,1209,1.03 [0.96-1.11],0.3466028962040101
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33791,3619,1.00 [0.96-1.04],0.9639853686546284
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,42469,158,0.80 [0.62-1.03],0.0795320642464764
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,43532,128,0.97 [0.77-1.22],0.7649368401714776
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37305,136,0.98 [0.78-1.22],0.8272540726366777
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",39254,2085,1.00 [0.94-1.06],0.9435392265524414
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,37317,148,1.13 [0.94-1.35],0.196752539339325
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,32902,2730,1.01 [0.96-1.06],0.7067959854028211
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40224,197,1.02 [0.86-1.22],0.7915143646797862
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,37253,84,0.96 [0.72-1.28],0.7729806565894763
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,37817,266,0.98 [0.84-1.15],0.8363378882463663
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,38084,915,1.04 [0.96-1.13],0.3473454288192255
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42919,608,0.92 [0.82-1.02],0.1222490652138143
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38508,957,0.95 [0.87-1.04],0.27958511903097
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43336,745,0.96 [0.87-1.06],0.435787684977106
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,43523,90,0.88 [0.65-1.19],0.4001077750667423
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37486,317,1.05 [0.92-1.20],0.4479824511165898
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34481,1251,1.00 [0.93-1.07],0.9976557023060082
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,38133,964,0.99 [0.92-1.08],0.8851213948451606
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37554,385,0.93 [0.81-1.07],0.3152855855567227
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30269,97,1.14 [0.92-1.42],0.2296614141648105
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,34336,4164,1.01 [0.97-1.05],0.6533366476309412
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31268,1096,1.05 [0.97-1.12],0.2342253445662847
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,42698,387,0.87 [0.75-1.01],0.0649981979832104
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",43451,105,0.98 [0.77-1.26],0.8917168003247224
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",39916,83,1.08 [0.84-1.40],0.5312573703264731
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,30303,131,0.97 [0.77-1.22],0.7754621790780991
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,37726,175,1.06 [0.89-1.27],0.5042068277858691
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30946,774,0.99 [0.90-1.09],0.8269482997158866
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37692,523,1.07 [0.96-1.18],0.2153441057242488
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37974,423,1.03 [0.91-1.16],0.6290170628575971
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,37859,308,0.96 [0.83-1.12],0.6367650127001496
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,34063,102,0.98 [0.76-1.26],0.8548926418447428
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",43530,97,0.93 [0.71-1.23],0.6120592697889229
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,38162,993,1.09 [1.01-1.17],0.0270708136119594
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],42477,166,0.95 [0.77-1.17],0.6299065749295978
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,41509,4340,1.02 [0.99-1.06],0.201064990336419
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37393,224,0.93 [0.77-1.12],0.433859882599122
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38429,878,1.07 [0.99-1.16],0.0687020085928218
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,41148,389,1.05 [0.93-1.19],0.3992745906101045
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,37876,325,1.07 [0.94-1.22],0.3051289647901404
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,40109,2558,1.02 [0.98-1.07],0.3287854317190198
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,39229,1678,1.02 [0.96-1.09],0.4731988941313597
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],37256,87,1.07 [0.83-1.37],0.6015643831620094
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42559,248,1.19 [1.04-1.35],0.0090924611497443
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37450,281,1.03 [0.89-1.19],0.6834855190784155
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,37301,132,1.05 [0.85-1.29],0.6499165229585517
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30265,93,0.96 [0.72-1.27],0.750892992168761
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,41995,2524,1.04 [1.00-1.10],0.0761090055276819
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17606,86,0.97 [0.74-1.27],0.8422551828713762
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22949,98,1.01 [0.79-1.29],0.91613619006934
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,43033,531,0.92 [0.81-1.03],0.1577114279955027
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,42646,144,0.76 [0.57-1.00],0.0504650255832335
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,41737,2266,1.00 [0.95-1.05],0.9229122901652906
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,43225,106,0.91 [0.69-1.19],0.47192038085648
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,43195,493,1.03 [0.92-1.15],0.606460573123777
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Cystitis,38459,388,1.03 [0.91-1.17],0.6132190642765646
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Dialysis,39581,110,0.86 [0.64-1.15],0.3038475255304739
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,18954,2747,0.95 [0.90-1.00],0.031683998344964
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23131,280,1.04 [0.91-1.20],0.5490622089942327
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17668,148,1.00 [0.82-1.22],0.9898096836938554
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17861,341,0.99 [0.87-1.12],0.8538314200949751
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18383,863,1.03 [0.94-1.11],0.5439420544229734
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,36397,8865,1.00 [0.98-1.03],0.8160525837739223
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,43242,123,0.98 [0.77-1.24],0.8657488414525351
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16376,169,0.99 [0.81-1.20],0.8887525744461868
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,39413,464,0.99 [0.87-1.11],0.8190498107227913
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18373,2166,0.96 [0.90-1.01],0.1272644972180706
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23077,343,1.01 [0.89-1.15],0.8736642648272058
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16401,194,0.92 [0.75-1.12],0.4020781669932797
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23150,110,0.77 [0.57-1.03],0.0773138457269149
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17787,267,1.03 [0.89-1.18],0.707821778103599
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,38195,124,0.81 [0.61-1.07],0.1453875399769483
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19624,2104,1.02 [0.97-1.08],0.4128326714056078
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16302,95,1.07 [0.84-1.36],0.5900377007175759
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17638,118,1.05 [0.85-1.29],0.6809754562838304
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",43545,110,1.00 [0.79-1.27],0.9838715736559038
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",43545,112,1.09 [0.88-1.35],0.4350234813176368
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,41795,3724,1.00 [0.95-1.04],0.8236694272755163
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39271,1200,0.94 [0.87-1.02],0.122994185433316
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22951,100,1.05 [0.83-1.32],0.6930971784220498
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43453,751,1.03 [0.94-1.13],0.4874970418323626
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16465,258,0.97 [0.82-1.14],0.7085260266696832
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16446,239,0.81 [0.66-0.99],0.0440314143777691
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16396,189,0.83 [0.67-1.04],0.1050794929664115
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,43497,116,1.32 [1.13-1.56],0.0006697735165503
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,40919,2848,1.01 [0.96-1.06],0.6787489539751128
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22912,178,0.96 [0.79-1.17],0.692627622354607
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17656,136,0.81 [0.62-1.06],0.1214698800415376
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17858,338,0.98 [0.85-1.12],0.7671404345557805
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17621,101,0.87 [0.65-1.16],0.3387519335448867
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17696,176,1.12 [0.96-1.32],0.1584656202147367
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39492,543,1.00 [0.89-1.11],0.9286782639407308
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,42944,242,1.10 [0.95-1.27],0.190733123873347
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17783,263,1.11 [0.97-1.27],0.1246981360589589
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17610,90,1.09 [0.86-1.37],0.4829278734072342
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18073,553,0.98 [0.88-1.09],0.6774161906680956
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17656,136,0.90 [0.71-1.14],0.3916256001558331
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18026,506,1.02 [0.92-1.14],0.6817023964824891
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,43205,86,0.97 [0.73-1.29],0.8493800086099824
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16420,213,0.92 [0.76-1.11],0.3869812471567533
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,43201,4252,1.01 [0.97-1.05],0.5717785243783418
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",39152,203,0.88 [0.72-1.08],0.2168782975222526
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39666,195,1.08 [0.92-1.28],0.3448118831312059
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42592,90,0.97 [0.73-1.28],0.8179251390690914
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38448,377,0.99 [0.86-1.13],0.8338038207322884
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,43163,661,0.92 [0.82-1.02],0.1280220505571433
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17638,118,1.02 [0.82-1.27],0.8720306098525451
